M&A Deal Summary |
|
|---|---|
| Date | 2017-11-03 |
| Target | OpenIOLabs |
| Sector | Information Technology |
| Buyer(s) | DeepMatter Group |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Life Science |
| Employees | 37 |
| Revenue | 1M GBP (2021) |
DeepMatter Group is a discovery company focussing on developing a number of projects targeting important new chemicals, materials, formulations, and pharmaceuticals in important commercial areas. Company have a passion for the discovery, design, and digitization of solutions combining chemical, materials and pharmaceutical discovery, and aiming to reduce the cost and feasibility of the discovery and manufacturing process over a range of areas. DeepMatter Group was founded in 2006 and is headquartered in Bristol, the United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: United Kingdom M&A | 2 of 2 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-25 |
Cronin 3D
Glasgow, United Kingdom Cronin 3D Ltd. owns and operates a platform which is used in the discovery, optimization, and portable manufacture of small molecules and nano materials for the pharmaceutical, formulation, and materials science industries. |
Buy | - |
